lumos.png
Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
13 mai 2021 09h00 HE | Lumos Pharma, Inc.
AUSTIN, Texas, May 13, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
logo.jpg.jpg
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
13 mai 2021 05h00 HE | ViaDerma, Inc.
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...
Cryo-Cell International, Inc. logo
Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials
10 mai 2021 09h00 HE | Cryo-Cell International, Inc.
MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell’s Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine...
Form fit function.png
Conformis Reports First Quarter 2021 Financial Results
05 mai 2021 16h05 HE | Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
lumos.png
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
05 mai 2021 16h01 HE | Lumos Pharma, Inc.
Newly released PK/PD data from prior study in PGHD support endogenous LUM-201 MOA and use of Predictive Enrichment Markers (PEMs) to identify patients likely to respond to LUM-201 Data presented...
Bio-Sig-Logo-horiz.jpg
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
04 mai 2021 09h15 HE | BioSig Technologies, Inc.
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians...
myriad logo.jpg
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
03 mai 2021 16h05 HE | Myriad Genetics, Inc.
Highlights: Revenue of $173.1 million increases 12% sequentiallyGAAP earnings per share of ($0.52), adjusted EPS of ($0.06) improves $0.06 sequentiallyTotal test volumes increase 5% sequentially...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Invited to Present at Wall Street Conference
03 mai 2021 12h00 HE | BioSig Technologies, Inc.
Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
lumos.png
Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021
28 avr. 2021 09h00 HE | Lumos Pharma, Inc.
AUSTIN, Texas, April 28, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will...
Bio-Sig-Logo-horiz.jpg
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
27 avr. 2021 09h30 HE | BioSig Technologies, Inc.
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatmentsNew installation...